Pegylated Liposomal Doxorubicin Hydrochloride for Ovarian Cancer

Source:
NIHR Journals Library - Health Technology Assessment
Publisher:
NIHR Journals Library – Health Technology Assessment
Publication date:
01 October 2002

Abstract

(2002) Pegylated Liposomal Doxorubicin Hydrochloride for Ovarian Cancer. NIHR Journals Library - Health Technology Assessment: Health Technology Assessment (HTA) publishes research information on the effectiveness, costs and broader impact of health technologies for those who use, manage and provide care in the NHS. Find out more about the HTA journal at https://www.journalslibrary.nihr.ac.uk/hta/#/.